Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: impact of adjuvant systemic treatment

被引：0
|
作者：
Hooning, M. [1 ]
Jager, A. [1 ]
Koppert, L. [2 ]
Van Deurzen, C. [3 ]
Collee, M. [4 ]
Hollestelle, A. [1 ]
Seynaeve, C. [1 ]
机构：
[1] Erasmus MC Canc Inst, Med Oncol, Rotterdam, Netherlands
[2] Erasmus MC Canc Inst, Surg Oncol, Rotterdam, Netherlands
[3] Erasmus MC Canc Inst, Pathol, Rotterdam, Netherlands
[4] Erasmus MC Canc Inst, Clin Genet, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [1] Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Graeser, Monika K.
    Engel, Christoph
    Rhiem, Kerstin
    Gadzicki, Dorothea
    Bick, Ulrich
    Kast, Karin
    Froster, Ursula G.
    Schlehe, Bettina
    Bechtold, Astrid
    Arnold, Norbert
    Preisler-Adams, Sabine
    Nestle-Kraemling, Carolin
    Zaino, Mohammad
    Loeffler, Markus
    Kiechle, Marion
    Meindl, Alfons
    Varga, Dominic
    Schmutzler, Rita K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5887 - 5892
  • [2] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [3] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [4] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    [J]. ONKOLOGIE, 2008, 31 : 28 - 28
  • [5] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    [J]. British Journal of Cancer, 2011, 104 : 1384 - 1392
  • [6] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    M Ahmed
    F Lalloo
    A Howell
    DG Evans
    [J]. Breast Cancer Research, 12
  • [7] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Ahmed, M.
    Lalloo, F.
    Howell, A.
    Evans, D. G.
    [J]. BREAST CANCER RESEARCH, 2010, 12 : S6 - S6
  • [8] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K.
    Gershman, S.
    Lynch, H. T.
    Ghadirian, P.
    Tung, N.
    Kim-Sing, C.
    Olopade, O. I.
    Domchek, S.
    McLennan, J.
    Eisen, A.
    Foulkes, W. D.
    Rosen, B.
    Sun, P.
    Narod, S. A.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
  • [9] The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer
    Narod, Steven A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 581 - 583
  • [10] The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer
    Steven A. Narod
    [J]. Breast Cancer Research and Treatment, 2011, 128 : 581 - 583
12345